Robert B. Perni
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine 9
- Hepatology top 1%
- Hepatitis C virus research 14
- Physiology top 1%
- Calcium signaling and nucleotide metabolism 5
- Epidemiology top 2%
- Hepatitis B Virus Studies 9
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 9
-
- Monoclonal and Polyclonal Antibodies Research 9
-
- Synthesis and biological activity 5
-
- Cancer therapeutics and mechanisms 5
Robert B. Perni
49 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 90
- Geriatrics and Gerontology 684
- Hepatology 868
- Physiology 214
- Epidemiology 988
- Infectious Diseases 424
Countries citing papers authored by Robert B. Perni
This map shows the geographic impact of Robert B. Perni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Perni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Perni more than expected).
Fields of papers citing papers by Robert B. Perni
This network shows the impact of papers produced by Robert B. Perni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Perni. The network helps show where Robert B. Perni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert B. Perni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 175 | |
| 2 | 2010 | 65 | |
| 3 | 2009 | 101 | |
| 4 | 2009 | 23 | |
| 5 | 2007 | 16 | |
| 6 | Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic. | 2006 | 17 |
| 7 | 2006 | 166 | |
| 8 | 2005 | 170 | |
| 9 | 2004 | 41 | |
| 10 | 2004 | 228 | |
| 11 | 2003 | 25 | |
| 12 | 2002 | 12 | |
| 13 | 2000 | 65 | |
| 14 | 2000 | 9 | |
| 15 | 1995 | 21 | |
| 16 | 1995 | 4 | |
| 17 | 1994 | 21 | |
| 18 | 1993 | 31 | |
| 19 | 1988 | 19 | |
| 20 | 1986 | 43 |
About Robert B. Perni
Robert B. Perni is a scholar working on Geriatrics and Gerontology, Hepatology and Toxicology, having authored 49 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), Hepatitis B Virus Studies (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), HIV/AIDS drug development and treatment (9 papers), Sirtuins and Resveratrol in Medicine (9 papers), Synthesis and biological activity (5 papers), Cancer therapeutics and mechanisms (5 papers) and Calcium signaling and nucleotide metabolism (5 papers). The work is most often cited by research in Geriatrics and Gerontology (684 citations), Hepatology (868 citations) and Physiology (214 citations). Robert B. Perni has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Ann D. Kwong, Chao Lin, Kai Lin, Han Dai, Robert K. Boeckman, Yu-Ping Luong, Cynthia A. Gates, David P. Carney, Yunyi Wei and Lei Jin. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.